Hain's recent results might not have been up to the mark, but the company still has potential as a long-term buy.
Organic food specialist Boulder Brands made a land grab in the freezer section in December, agreeing to buy Evol Foods, an organic manufacturer of frozen meals. With a more diversified product portfolio, is it a good bet for investors?
Delays and opposition beset its mega three-way acquisition.
J.M. Smucker delivered a weak earnings report, as it faces increasing competition in its core segments from rivals Hormel Foods and ConAgra.
Campbell Soup reports second-quarter earnings this Friday. Will it be able to buck the recent slump that has dogged it and competitors Kellogg and General Mills?
Cal-Maine Foods offers stability just like General Mills and unlike Campbell Soup Company.
Industrial biotech company Solazyme is expected to start up commercial scale operations of its first two biorefineries soon. Where should investors set their expectations for the company in 2014 and what does the start-up mean for feedstock suppliers Bunge and Archer Daniels Midland?
Beneficial commodities prices and another strategic acquisition led this hidden gem to a blowout quarter.
With shares off their highs from earlier this year, General Mills has to look for growth beyond the breakfast table.
Solazyme recently announced that it was pushing back the start-up of its commercial scale facility in Brazil, built with partner Bunge, by a few months. The news serves as a reminder that delays are always possible for developmental companies. Are more on the way in 2014?